IFNG and COVID-19: IFNγ serum levels in SARS-CoV-2 infected patients are also closely related to the development of clinical symptoms, causing flu-like symptoms as general malaise, headaches, fever and fatigue, but increased serum INFγ levels is usually correlated to non-severe COVID-19 [188].